Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaKidZ: Ezetimibe in Diabetic Kidney Disease
NCT04589351Phase 3Unknown
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Oct 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe in diabetic kidney disease (DKD), sponsored by Steno Diabetes Center Copenhagen. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT04589351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589351.